SCHEMBL18878293

SCHEMBL18878293

CC1(C)c2ccccc2-c2c(-c3cccc(-c4nc(-c5ccc(-c6ccccc6)cc5)nc(-c5ccc(-c6ccccc6)cc5)n4)c3)cccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.38
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
ALDH1A1 P00352 2/20 0.36
MAPT P10636 2/20 0.36
HPGD P15428 2/20 0.36
ADORA3 P0DMS8 2/20 0.36
ADORA2A P29274 2/20 0.36
ADORA2B P29275 2/20 0.36
ADORA1 P30542 2/20 0.36
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36
LMNA P02545 2/20 0.35
KDM4E B2RXH2 1/20 0.35
GLA P06280 1/20 0.35
PDK2 Q15119 5/20 0.35
POLB P06746 1/20 0.34
NTSR1 P30989 1/20 0.33
RAB9A P51151 1/20 0.33
RARA P10276 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18878287 1.00 L3MBTL1 (0.38) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL17887185 0.99 L3MBTL1 (0.37) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL18463349 0.97 L3MBTL1 (0.38) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL22986991 0.97 L3MBTL1 (0.40) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL18463575 0.96 L3MBTL1 (0.37) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL23697564 0.96 L3MBTL1 (0.37) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL18463353 0.96 L3MBTL1 (0.37) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL23697106 0.96 L3MBTL1 (0.37) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL17151621 0.96 L3MBTL1 (0.37) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL26937585 0.96 L3MBTL1 (0.37) L3MBTL1MEN1KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210074925-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2021-03-11 US disclosed
US-20170148995-A1 ORGANIC LIGHT EMITTING DISPLAY DEVICE LG DISPLAY CO., LTD. (KR) 2017-05-25 US disclosed
US-20170148995-A1 ORGANIC LIGHT EMITTING DISPLAY DEVICE LG DISPLAY CO., LTD. (KR) 2017-05-25 US disclosed
US-20160346270-A1 BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2 AUSPEX PHARMACEUTICALS, INC. 2016-12-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160346270-A1 BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2 SLC18A2, SLC6A2, SLC18A1 L3MBTL1 4418/4885MEN1 3213/4885KMT2A 626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.